Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2021 Filed Jun 21, 2021 16:42 UTC |
Chen Timothy Yung-ChengDirector
|
GrantOrdinary Shares | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000124 · wf-form4_162430808259171.xml · nonDerivative · entry 1 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:34 UTC |
su Jingshyh SDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,498 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001651308-21-000119 · wf-form4_162430762887048.xml · derivative · entry 2 su Jingshyh S · CIK 0001315720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,498 Underlying: Ordinary Shares · 17,498 shares Expires 2031-06-15 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 16:34 UTC |
su Jingshyh SDirector
|
GrantOrdinary Shares | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000119 · wf-form4_162430762887048.xml · nonDerivative · entry 1 su Jingshyh S · CIK 0001315720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:38 UTC |
HOOPER ANTHONY CDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,498 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001651308-21-000122 · wf-form4_162430788386168.xml · derivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,498 Underlying: Ordinary Shares · 17,498 shares Expires 2031-06-15 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:38 UTC |
HOOPER ANTHONY CDirector
|
GrantOrdinary Shares | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000122 · wf-form4_162430788386168.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:50 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
GrantShare Option (Right to Buy) · Derivative | 241,839 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001651308-21-000129 · wf-form4_162430860110409.xml · derivative · entry 6 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,839 Underlying: Ordinary Shares · 241,839 shares Expires 2031-06-15 F6 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F6 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 16, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:50 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
GrantOrdinary Shares | 39,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000129 · wf-form4_162430860110409.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,786,271 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:49 UTC |
Wu XiaobinPresident, COO & GM China
|
GrantShare Option (Right to Buy) · Derivative | 483,678 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001651308-21-000128 · wf-form4_162430851498091.xml · derivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,678 Underlying: Ordinary Shares · 483,678 shares Expires 2031-06-15 F5 · derivative.exercise_price: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. F5 · shares: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 16, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject toaccelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:49 UTC |
Wu XiaobinPresident, COO & GM China
|
GrantOrdinary Shares | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000128 · wf-form4_162430851498091.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,213,729 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vestingupon certain termination events following a change in control. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:39 UTC |
Glazer Donald W.Director
|
GrantShare Option (Right to Buy) · Derivative | 17,498 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001651308-21-000123 · wf-form4_162430797209409.xml · derivative · entry 2 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,498 Underlying: Ordinary Shares · 17,498 shares Expires 2031-06-15 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:39 UTC |
Glazer Donald W.Director
|
GrantOrdinary Shares | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000123 · wf-form4_162430797209409.xml · nonDerivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,754,529 F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:35 UTC |
Sanders Corazon (Corsee) D.Director
|
GrantShare Option (Right to Buy) · Derivative | 17,498 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001651308-21-000120 · wf-form4_162430771425098.xml · derivative · entry 2 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,498 Underlying: Ordinary Shares · 17,498 shares Expires 2031-06-15 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares. F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:35 UTC |
Sanders Corazon (Corsee) D.Director
|
GrantOrdinary Shares | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000120 · wf-form4_162430771425098.xml · nonDerivative · entry 1 Sanders Corazon (Corsee) D. · CIK 0001796536 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 24, 2021 16:26 UTC |
Yi QingqingDirector
|
GrantShare Option (Right to Buy) · Derivative | 17,498 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0000902664-21-003255 · ownership.xml · derivative · entry 2 Yi Qingqing · CIK 0001662556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,498 Underlying: Ordinary Shares · 17,498 shares Expires 2031-06-15 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 16, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon change of control or certain termination events. Read SEC document |
| June 16, 2021 Filed Jun 24, 2021 16:26 UTC |
Yi QingqingDirector
|
GrantOrdinary Shares | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000902664-21-003255 · ownership.xml · nonDerivative · entry 1 Yi Qingqing · CIK 0001662556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 36,868 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · derivative · entry 11 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,926 Underlying: Ordinary Shares · 36,868 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F11 · derivative.exercise_date: These securities vest over a three-year period as follows: 1/3 of these securities become exercisable on each anniversary of February 8, 2016. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 305 | $353.69 | $107,874.60 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 9 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.21 to $353.85, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,339 | $352.74 | $472,315.11 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 8 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.21 to $353.19, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 508 | $351.79 | $178,706.88 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 7 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,644 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.20 to $352.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 684 | $350.08 | $239,451.98 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 6 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,152 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
Exercise / conversionAmerican Depositary Shares | 2,836 | $31.59 | $89,589.24 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 5 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 41,132 | $0.00 Strike: $2.43 | $0.00 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · derivative · entry 10 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,794 Underlying: Ordinary Shares · 41,132 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F11 · derivative.exercise_date: These securities vest over a three-year period as follows: 1/3 of these securities become exercisable on each anniversary of February 8, 2016. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 600 | $352.74 | $211,642.02 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 4 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.22 to $353.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,201 | $351.70 | $422,389.30 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 3 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.16 to $352.08, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,363 | $350.43 | $477,638.00 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 2 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,801 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.10 to $351.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:36 UTC |
Chen Timothy Yung-ChengDirector
|
Exercise / conversionAmerican Depositary Shares | 3,164 | $31.59 | $99,950.76 |
DisclosureSEC source: 0001651308-21-000114 · wf-form4_162344374129626.xml · nonDerivative · entry 1 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:46 UTC |
Wang LaiGlobal Head of R&D
|
SaleAmerican Depositary Shares | 656 | $354.26 | $232,392.33 |
DisclosureSEC source: 0001651308-21-000108 · wf-form4_162327158340350.xml · nonDerivative · entry 2 Wang Lai · CIK 0001852291 · Global Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.646 to $354.54, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:45 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 603 | $351.55 | $211,985.55 |
DisclosureSEC source: 0001651308-21-000107 · wf-form4_162327150511384.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:49 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 2 | $351.53 | $703.05 |
DisclosureSEC source: 0001651308-21-000110 · wf-form4_162327176662694.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:49 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 571 | $353.57 | $201,888.13 |
DisclosureSEC source: 0001651308-21-000110 · wf-form4_162327176662694.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.37 to $353.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:49 UTC |
Wu XiaobinPresident, COO & GM China
|
SaleAmerican Depositary Shares | 2,825 | $352.33 | $995,326.04 |
DisclosureSEC source: 0001651308-21-000110 · wf-form4_162327176662694.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.1054 to $352.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:48 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 650 | $354.16 | $230,202.51 |
DisclosureSEC source: 0001651308-21-000109 · wf-form4_162327168180794.xml · nonDerivative · entry 2 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon a sale event. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.65 to $354.25, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:07 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 7,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000106 · wf-form4_162310002440774.xml · nonDerivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,746,729 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 540 | $362.64 | $195,827.71 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 10 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F8 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a performance-based restricted share unit award previously granted to the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.57 to $362.72, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:51 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 69,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000100 · wf-form4_162275345321771.xml · nonDerivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,754,129 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
GrantAmerican Depositary Shares | 540 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F1 · shares: Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
GrantOrdinary Shares | 7,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 1 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,772 F1 · shares: Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · derivative · entry 11 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,075 Underlying: Ordinary Shares · 19,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F11 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $359.42 | $35,942.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 9 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 147 | $358.36 | $52,679.46 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 8 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.01 to $358.53, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 353 | $357.50 | $126,196.62 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 7 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.93 to $357.81, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 300 | $356.21 | $106,863.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 6 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.85 to $356.41, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 500 | $354.97 | $177,487.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.73 to $355.22, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $352.85 | $35,285.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:40 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-21-000099 · wf-form4_162266637975477.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 21:10 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000098 · wf-form4_162258182753878.xml · nonDerivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823,129 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:32 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 88,231 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001651308-21-000092 · wf-form4_162085153052240.xml · derivative · entry 11 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4 Underlying: Ordinary Shares · 88,231 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: These securities vest over a five-year period as follows: 20% on May 20, 2012, and the remaining in 48 successive equal monthly installments, subject to continued service. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:32 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 389 | $303.10 | $117,905.94 |
DisclosureSEC source: 0001651308-21-000092 · wf-form4_162085153052240.xml · nonDerivative · entry 10 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.01 to $303.325, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:32 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 311 | $302.21 | $93,987.90 |
DisclosureSEC source: 0001651308-21-000092 · wf-form4_162085153052240.xml · nonDerivative · entry 9 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.93 to $302.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:32 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 1,594 | $300.20 | $478,518.00 |
DisclosureSEC source: 0001651308-21-000092 · wf-form4_162085153052240.xml · nonDerivative · entry 8 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected solely to cover the exercise cost and satisfy tax obligations for the share options that were exercised. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.62, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.